Accenture plc

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 2,123 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Fiscal year ends 31 August. The most recent Form 10-K is for FY2025 (period ended 31 August 2025, filed 10 October 2025); the most recent Form 10-Q is for Q3 FY2026 (period ended 31 May 2026, filed 18 June 2026), confirmed as the latest via the EDGAR submissions feed as of 17 August 2026. The FY2026 10-K (period ending 31 August 2026) had not been filed as of this research date.
• Share structure: Accenture plc (Irish domiciled, CUSIP G1151C101, NYSE: ACN) has Class A ordinary shares (listed, one vote per share, entitled to dividends) and Class X ordinary shares (unlisted, held only by Accenture Holdings partners, one vote per share, no dividend or liquidation rights, converted/redeemed as the partner's underlying Accenture Holdings interest is exchanged for Class A shares). As of 4 June 2026: Class A issued 667,510,210 of which 55,568,101 are held in treasury by Accenture itself (net outside holders: 611,942,109); Class X outstanding 300,673, held by 14 holders of record per the FY2025 10-K.
• Denominator policy for this file: every register row states its own pct_denominator explicitly and none are mixed silently. Rows sourced from 13F filings and the proxy's insider table use Class A ordinary shares outstanding NET of Accenture's own treasury holding, matched to the date closest to that row's as_of (611,942,109 for the 30 June 2026 13F cohort; 615,306,754 for Vanguard's 31 Dec 2025 13F; 615,355,540 for the proxy's 1 Dec 2025 insider table). The one exception is the treasury row itself, which necessarily uses the GROSS issued Class A count (667,510,210) as its denominator, since expressing treasury shares as a percentage of a total that already excludes them would be circular.
• Accenture plc itself files Form 13F-HR under CIK 0001467373 (most recent, period 30 September 2024, filed 31 October 2024, and consistently for prior quarters back to at least 2023). Every one of these filings reports a single information-table line reading 'No securities', CUSIP 000000000, value $0 and 0 shares: Accenture is a technical 13F filer with nothing to report, not an investment manager holding a portfolio. This is unrelated to Accenture's own holdings as an operating company and is not treated as a holding.
• Holdings is empty and that is a sourced finding, not a gap. The FY2025 10-K (period ended 31 August 2025) and the Q3 FY2026 10-Q (period ended 31 May 2026) were both fetched and searched for 'Accenture Ventures', 'equity method', 'non-marketable', 'measurement alternative', 'strategic investment', 'unrealized gain' and 'investments in unconsolidated'. Both disclose only a combined, two-line non-current investments table with no investee named: as of 31 May 2026, equity method investments $356,422,000 and investments without readily determinable fair values $568,902,000 (total $925,324,000), versus $355,276,000 and $365,984,000 (total $721,260,000) as of 31 August 2025. The 10-K states these are equity securities in privately held companies, which is exactly where Accenture Ventures' growth-stage technology investments would sit, but per the brief's rule against assigning a combined balance to any one investee, every individual holding is recorded as null and omitted from the holdings array rather than guessed; the combined totals are recorded here instead.
• The 2025 proxy's own 'Beneficial Ownership of More Than 5%' table (as of 1 December 2025, sourced to Schedule 13G/A filings) lists The Vanguard Group at 63,802,647 shares (10.4%, from a 13G/A filed 7 April 2025) and BlackRock, Inc. at 47,931,575 shares (7.8%, from a similarly dated 13G/A). Both are stale relative to the managers' own more recent 13F-HR figures used in the register above (Vanguard 66,070,930 as of 31 Dec 2025; BlackRock 62,162,363 as of 30 June 2026). The register uses the managers' own, more recent 13F data, consistent with the brief's preference for the freshest primary source.
• The EDGAR submissions feed's 'recent' filings window (covering 23 March 2023 to 6 August 2026 under this CIK) contains no SC 13G or SC 13G/A filed after 13 February 2024, which does not match the proxy's citation of an April 2025 13G/A for Vanguard; that specific 2025 filing was not independently located or fetched within the time budget and is relayed here only as reported by the proxy.
• Market capitalisation ($108.25 billion, close of $176.89 on 14 August 2026) and shares outstanding (611.94 million) are as published by stockanalysis.com. Cross-check: 611,942,109 (this file's own net-of-treasury Class A count derived from the 4 June 2026 10-Q cover page) closely matches stockanalysis's independently reported 611.94 million, despite the roughly two-month gap between the two dates.
• ACN's stock price fell sharply between the two 13F reference dates used in this file: roughly $268 per share implied by Vanguard's 31 December 2025 position value, versus roughly $124 per share implied by the 30 June 2026 13F cohort (BlackRock, State Street, Geode, FMR, Morgan Stanley, JPMorgan), before recovering to $176.89 by 14 August 2026. This is a real, large move reflected consistently across five independent 30 June 2026 filings, not a data error; flagged here so the swing is not mistaken for a mismatched CUSIP or a stock split (no split was reported).